P2RY2 and breast carcinoma: Breast cancer cell lines with more exATP are highly metastatic (281), and migration and invasion are moderated through MEK/ERK1/2-dependent signaling pathway activation (121, 279, 282) and ATP-P2Y2R-β-catenin (280).